View Older Stories View More Recent Stories

Oct 6, 2023 07:05AM Form D/A Viking Global Equities
Oct 6, 2023 06:55AM Form D/A Viking Global Equities
Sep 28, 2023 08:04AM AI startup AlphaSense valued at $2.5 billion after latest funding round
Sep 28, 2023 08:00AM AlphaSense Grows to $2.5 Billion Valuation, Securing $150 Million in Series E Funding Led by BOND
Sep 27, 2023 11:35AM Battelle Ranked Fifth on Fortune’s 2023 Change the World List for Its PFAS Annihilator® Technology
Sep 26, 2023 08:17AM Mythic Therapeutics Receives FDA Fast Track Designation for MYTX-011 for Patients with Non-Small Cell Lung Cancer (NSCLC) with cMET Overexpression
Sep 22, 2023 05:25PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Sep 21, 2023 05:11PM Form SC 13G RayzeBio, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Sep 21, 2023 05:01PM Form 4 RayzeBio, Inc. For: Sep 19 Filed by: Viking Global Opportunities Drawdown Portfolio GP LLC
Sep 19, 2023 08:17AM Mythic Therapeutics to Present New Preclinical Data on MYTX-011, Investigational cMET-Targeting Antibody-Drug Conjugate (ADC), at the AACR-NCI-EORTC International Conference on Molecular Targets and C
Sep 14, 2023 09:46PM Form 3 RayzeBio, Inc. For: Sep 14 Filed by: VIKING GLOBAL INVESTORS LP
Sep 14, 2023 09:45PM Form 3 RayzeBio, Inc. For: Sep 14 Filed by: VIKING GLOBAL INVESTORS LP
Sep 12, 2023 06:02AM Walgreens Boots Alliance (WBA) and Pearl Health Announce Strategic Partnership to Advance Value-Based Care Delivery
Sep 12, 2023 06:00AM Walgreens and Pearl Health Announce Strategic Partnership to Advance Value-Based Care Delivery
Aug 30, 2023 08:45PM Form 4 Inhibrx, Inc. For: Aug 28 Filed by: VIKING GLOBAL INVESTORS LP
Aug 29, 2023 09:01AM Inhibrx Inc. (INBX) Announces $200M Financing at $19.35/sh
Aug 29, 2023 09:00AM Inhibrx Announces $200 Million Private Placement Financing
Aug 24, 2023 04:30PM Form SC 13G VALVOLINE INC Filed by: VIKING GLOBAL INVESTORS LP
Aug 14, 2023 04:25PM Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
Aug 9, 2023 12:06AM Hedge fund Viking reopens flagship fund after decade -sources
Jul 26, 2023 09:03AM Patina teams with Humana to expand reach of convenient, relationship-centered primary care for people with Medicare
Jul 20, 2023 06:02AM Form SC 13D/A BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Jul 19, 2023 09:34PM Form 4 BridgeBio Pharma, Inc. For: Jul 18 Filed by: VIKING GLOBAL INVESTORS LP
Jul 18, 2023 09:31PM Form 144 BridgeBio Pharma, Inc. Filed by: Viking Global Opportunities Illiquid Investments Sub-Master LP
Jul 18, 2023 09:07AM State of New Hampshire Chooses Revive Environmental’s PFAS Annihilator™ System to Destroy Harmful Firefighting Foam Stockpiles
Jul 12, 2023 08:00AM With New $30M Series A Extension, Allonnia Takes Aim At Scaling Solutions to the World’s Toughest Environmental Challenges
Jun 26, 2023 05:12PM Form 4 Roivant Sciences Ltd. For: Jun 22 Filed by: Viking Global Opportunities GP LLC
Jun 26, 2023 05:06PM Form SC 13G/A Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Jun 20, 2023 04:31PM Form SC 13G NewAmsterdam Pharma Co Filed by: VIKING GLOBAL INVESTORS LP
Jun 16, 2023 04:18PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Jun 14, 2023 08:32AM Pearl Health Partners with Story Health to Provide Scalable Specialty Cardiac Care to Medicare Beneficiaries
Jun 6, 2023 08:45AM Ecovative Raises Over $30 Million, Funding Global Distribution of Planet-Friendly Fashion and Food
Jun 5, 2023 05:00PM Form SC 13G Verastem, Inc. Filed by: VIKING GLOBAL INVESTORS LP
May 31, 2023 09:00AM The Future Is Bright -- Lightmatter Raises $154M to Deliver Photonic Products to Customers
May 16, 2023 05:28PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
May 16, 2023 08:00AM Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
May 15, 2023 04:21PM Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
May 15, 2023 02:29PM Kavitha Dasu Named Battelle Inventor of the Year
May 11, 2023 05:51PM Form 4 4D Molecular Therapeutic For: May 09 Filed by: Viking Global Opportunities GP LLC
May 10, 2023 08:00AM Pearl Health releases Top 50 Value-Based Care Thinkers of 2023
May 8, 2023 08:00AM Solarea Bio Announces First Close of Series B Financing Round
May 4, 2023 12:18PM Revive Environmental’s PFAS Annihilator™ Technology Recognized With Two Honors from Fast Company 2023 World Changing Ideas Awards
May 1, 2023 07:08AM Revive Environmental PFAS Annihilator™ Deployed in First-to-Market Commercial Destruction of “Forever Chemicals”
Apr 27, 2023 04:33PM Form SC 13D/A Cazoo Group Ltd Filed by: VIKING GLOBAL INVESTORS LP
Apr 27, 2023 04:56AM GPS Rebrands as “Thredd” to Reflect Its Unique Position as the Go to Payments Partner of Innovators Worldwide
Apr 20, 2023 06:30AM Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer
Apr 18, 2023 01:30PM Mythic Therapeutics Presents Preclinical Data on Investigational cMET-Targeting Antibody-Drug Conjugate (ADC) MYTX-011 at American Association for Cancer Research (AACR) Annual Meeting
Apr 11, 2023 10:11AM AlphaSense valued at $1.8 billion after CapitalG-backed fundraise
Apr 11, 2023 09:30AM ID.me Appoints Samantha Greenberg as Chief Financial Officer and Raises $132 Million in Series D Funding
Apr 11, 2023 09:00AM AlphaSense Raises $100M Led By Alphabet's CapitalG to Fuel Innovation in AI and Market Intelligence
View More Recent Stories View Older Stories